Brief: Medincell: Completion Of Patient Enrollment In Phase 3 Study Of F14
30/08/2023 17:41
Aug 30 (Reuters) - Medincell SA MEDCL.PA :
* MEDINCELL ANNOUNCES SUCCESSFUL COMPLETION OF PATIENT
ENROLLMENT
IN THE PHASE 3 STUDY OF F14 (MDC-CWM), A FIRST-IN-CLASS THERAPY
FOR LOCALIZED PAIN RELIEF AFTER TOTAL KNEE REPLACEMENT
* EFFICACY RESULTS ANTICIPATED IN Q1 2024
Source text for Eikon: ID:nBw5yWhhMa
Further company coverage: MEDCL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))